Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Targeting the right antigens in the right patients

May 4, 2021 J Clin Invest

Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis co-infection

Riou, C., Du Bruyn, E., Stek, C., Daroowala, R., Goliath, R.T., Abrahams, F., Said-Hartley, Q., Allwood, B.W., Hsiao, N.Y., Wilkinson, K.A., Lindestam Arlehman, C.S., Sette, A., Wasserman, S., and Wilkinson, R.J.

Apr 23, 2021 Vaccines (Basel)

Balanced cellular and humoral immune responses targeting multiple antigens in adult receiving a quadrivalent inactivated influenza vaccine

Yu, E.D., Grifoni, A., Sutherland, A., Voic, H., Wang, E., Frazier, A., Jimenez-Truque, N., Yoder, S., Welsh, S., Wooden, S., Koff, W., Creech, B., Sette, A.*, and da Silva Antunes, R.

Apr 21, 2021 J Am Chem Soc

Backbone Modifications of HLA-A2-Restricted Antigens Induce Diverse Binding and T Cell Activation Outcomes

Gibadullin, R., Randall, C.J., Sidney, J., Sette, A., and Gellman, S.H.